Literature DB >> 31036342

Perspectives on PARPs in S Phase.

Hana Hanzlikova1, Keith W Caldecott2.   

Abstract

Accurate copying of DNA during S phase is essential for genome stability and cell viability. During genome duplication, the progression of the DNA replication machinery is challenged by limitations in nucleotide supply and physical barriers in the DNA template that include naturally occurring DNA lesions and secondary structures that are difficult to replicate. To ensure correct and complete replication of the genome, cells have evolved several mechanisms that protect DNA replication forks and thus maintain genome integrity and stability during S phase. One class of enzymes that have recently emerged as important in this process, and therefore as promising targets in anticancer therapy, are the poly(ADP-ribose) polymerases (PARPs). We review here the roles of these enzymes during DNA replication as well as their impact on genome stability and cellular viability in normal and cancer cells.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  DNA replication stress; DNA strand break repair; Okazaki fragment; PARP1; PARP2; poly(ADP-ribose)

Mesh:

Substances:

Year:  2019        PMID: 31036342     DOI: 10.1016/j.tig.2019.03.008

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  16 in total

1.  PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response.

Authors:  Julia M Reber; Jovana Božić-Petković; Michelle Lippmann; Marvin Mazzardo; Asisa Dilger; Rebecca Warmers; Alexander Bürkle; Aswin Mangerich
Journal:  Cell Biol Toxicol       Date:  2022-07-01       Impact factor: 6.691

Review 2.  DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives.

Authors:  Öykü Gönül Geyik; Giulia Anichini; Engin Ulukaya; Fabio Marra; Chiara Raggi
Journal:  Cells       Date:  2022-04-26       Impact factor: 7.666

3.  Tuning drug binding.

Authors:  Dea Slade; Sebastian Eustermann
Journal:  Science       Date:  2020-04-03       Impact factor: 47.728

4.  Neuronal enhancers are hotspots for DNA single-strand break repair.

Authors:  Wei Wu; Sarah E Hill; William J Nathan; Jacob Paiano; Elsa Callen; Dongpeng Wang; Kenta Shinoda; Niek van Wietmarschen; Jennifer M Colón-Mercado; Dali Zong; Raffaella De Pace; Han-Yu Shih; Steve Coon; Maia Parsadanian; Raphael Pavani; Hana Hanzlikova; Solji Park; Seol Kyoung Jung; Peter J McHugh; Andres Canela; Chongyi Chen; Rafael Casellas; Keith W Caldecott; Michael E Ward; André Nussenzweig
Journal:  Nature       Date:  2021-03-25       Impact factor: 49.962

5.  Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair.

Authors:  Hana Hanzlikova; Evgeniia Prokhorova; Katerina Krejcikova; Zuzana Cihlarova; Ilona Kalasova; Jan Kubovciak; Jana Sachova; Richard Hailstone; Jan Brazina; Shereen Ghosh; Sebahattin Cirak; Joseph G Gleeson; Ivan Ahel; Keith W Caldecott
Journal:  Nat Commun       Date:  2020-07-07       Impact factor: 14.919

Review 6.  Nuclear PARPs and genome integrity.

Authors:  Kameron Azarm; Susan Smith
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 7.  PARP and PARG inhibitors in cancer treatment.

Authors:  Dea Slade
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

8.  Top1-PARP1 association and beyond: from DNA topology to break repair.

Authors:  Srijita Paul Chowdhuri; Benu Brata Das
Journal:  NAR Cancer       Date:  2021-02-01

9.  Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.

Authors:  Ke Cong; Min Peng; Arne Nedergaard Kousholt; Wei Ting C Lee; Silviana Lee; Sumeet Nayak; John Krais; Pamela S VanderVere-Carozza; Katherine S Pawelczak; Jennifer Calvo; Nicholas J Panzarino; John J Turchi; Neil Johnson; Jos Jonkers; Eli Rothenberg; Sharon B Cantor
Journal:  Mol Cell       Date:  2021-07-02       Impact factor: 19.328

10.  Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells.

Authors:  Hongge Wang; Shan Zhang; Liyan Song; Meng Qu; Zhihua Zou
Journal:  Oncogene       Date:  2020-02-06       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.